Your browser doesn't support javascript.
loading
The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas.
Peh, Jessie; Fan, Timothy M; Wycislo, Kathryn L; Roth, Howard S; Hergenrother, Paul J.
Afiliação
  • Peh J; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois. Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois.
  • Fan TM; Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois. Department of Veterinary Clinical Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois.
  • Wycislo KL; Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois.
  • Roth HS; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois. Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois.
  • Hergenrother PJ; Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois. Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois. hergenro@uiuc.edu.
Mol Cancer Ther ; 15(8): 1859-69, 2016 08.
Article em En | MEDLINE | ID: mdl-27297867

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Proteínas Proto-Oncogênicas B-raf / Caspase 3 / Indóis / Melanoma / Mutação / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sulfonamidas / Proteínas Proto-Oncogênicas B-raf / Caspase 3 / Indóis / Melanoma / Mutação / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article